| |
| |
|
| Insider
Information: |
Schafer Carol |
| Relationship: |
Director |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
102,585 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,138,411 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
102,585 |
|
|
| Total
Value |
$1,138,411 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
Officer |
2003-12-01 |
1,000 |
|
0 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
Director |
2021-01-04 |
48,488 |
2018-12-19 |
0 |
Premium* |
|
|
Insmed Inc |
INSM |
Director |
2023-05-11 |
45,097 |
2020-04-01 |
0 |
Premium* |
|
|
Repare Therapeutics Inc. |
RPTX |
Director |
2020-06-23 |
8,000 |
2020-06-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INSM |
Insmed Inc |
Director |
– • – |
2023-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
13,192 |
45,097 |
0 |
- |
|
| INSM |
Insmed Inc |
|
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,645 |
31,905 |
0 |
- |
|
| INSM |
Insmed Inc |
|
• • – |
2021-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,558 |
17,260 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2021-01-04 |
4 |
A |
$4.02 |
$14,552 |
D/D |
3,620 |
48,488 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-10-01 |
4 |
A |
$2.25 |
$13,750 |
D/D |
6,111 |
44,868 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-07-01 |
4 |
A |
$1.79 |
$13,749 |
D/D |
7,681 |
38,757 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2020-06-23 |
4 |
B |
$20.00 |
$160,000 |
D/D |
8,000 |
8,000 |
2.39 |
- |
|
| INSM |
Insmed Inc |
Director |
– • – |
2020-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,097 |
9,702 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-04-01 |
4 |
A |
$1.28 |
$13,610 |
D/D |
10,633 |
31,076 |
0 |
- |
|
| INSM |
Insmed Inc |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,605 |
1,605 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2019-10-01 |
4 |
A |
$2.67 |
$13,612 |
D/D |
5,098 |
20,443 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2019-07-01 |
4 |
A |
$2.61 |
$13,517 |
D/D |
5,179 |
15,345 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2019-04-01 |
4 |
A |
$2.59 |
$13,380 |
D/D |
5,166 |
10,166 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2018-12-19 |
4 |
B |
$3.33 |
$16,671 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP Finance - CommunicationsOff |
• – – |
2003-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
